Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01538004
Other study ID # 12-0217
Secondary ID
Status Withdrawn
Phase N/A
First received February 17, 2012
Last updated April 2, 2014
Start date March 2014
Est. completion date November 2014

Study information

Verified date April 2014
Source North Toronto Primary Care Research Network
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Observational

Clinical Trial Summary

The use of automated blood pressure measurement (ABPM) devices in the office setting is increasingly recognized as superior to manual BP measurement. Current guidelines recommend that patients be alone in a quiet room, with no interactions with health care professionals during the readings; in practice, this means using an exam room. However, we found no evidence supporting the location of ABPM. Furthermore, exam rooms are constantly being used in primary care offices, so this may not be practical in routine care.

For this study, fifty consecutive consenting patients age 18 or more in each of seven community based primary care offices will randomly be allocated to either ABPM in an exam room, or in a non-private area of the clinic. After being tested in the first location they will then be tested in the second location with the same device. The main outcome will be the mean value of the last five systolic blood pressures for each location within offices. Secondary measures will include blood pressures for patients with or without hypertension, a comparison of the initial and second set of blood pressures and of the effect of office noise in decibels on BP readings.

New technology is more readily adopted if barriers to use are minimized. If we find no differences in BP readings between office locations, clinicians will then have the option to use an additional office area to implement the automated BP measurement device.


Description:

Following the design of our pilot study, patients consenting to two sets of blood pressure readings will be randomly allocated using a random number table to either automated blood pressure measurement using a BpTRU device in an exam room (private area without any traffic or staff) with the door closed, or BpTRU in an open (non-private area) of the clinic with routine office traffic and noise levels. Patients randomized to the private area first will be subsequently tested in the non-private area and those randomized to the non-private area first will then be tested in the private area. A single portable BpTRU machine will be used for all recordings. A research assistant will be trained on the use of the equipment with at least five supervised training readings. The BpTRU device will be placed on the patient's arm and readings will be recorded by the research assistant. The first reading will be done with the research assistant present to ensure proper placement and recording. The patient will then be left alone for the subsequent five measurements separated by one minute intervals. This will be immediately followed by a second set of readings in the alternate location. During both sets of readings the patient will be seated comfortably in a chair with arms and will be instructed not to talk or cross their legs. The same arm will be used for both sets of measurements with the blood pressure cuff at heart level. The research assistant will record the average of the last five out of six blood pressure readings for each office location, in accordance with the manufacturer's recommendations and previous studies.

The research assistant will record decibel levels in each location during BP readings using a Reed Sound Level Meter C-322 (Reed Instruments, Ste-Anne-de-Bellevue, Quebec, Canada). The sound level meter includes a data logger, and the mean decibel level per location for each set of readings will be recorded. The assistant will be trained in the use of the sound meter and logger and will use it during the five supervised BP training readings. The research assistant will also measure and record the patient's weight in kg, height in cm, and will collect information on patient's gender and self reported history of hypertension.

Planned sample size and analysis Our sample size is based on equivalence of BpTRU measurement done in non private office areas as compared to measurement done in private office areas, using the results of our pilot study. We consider differences of less than 5 mm Hg in systolic blood pressure to be clinically equivalent. In order to demonstrate equivalence for our primary outcome, and accounting for clustering effect in primary care offices, using a power of 80% and a two sided alpha level of 0.05 to conclude equivalency for a difference of 5 mm Hg or less, we will need to recruit 350 patients. Our planned recruitment is therefore fifty patients per office and seven office locations. 175 patients (25 per office location) will be randomly allocated to BpTRU measurement in a private exam room first and 175 will be allocated to an open area first.

Following the analytic methods used in our pilot study, we will use a random effect regression model to account for repeated measures within each participant for analyzing the data. Regression analysis will be undertaken to compare the measures and results will be adjusted for clustering effect. All tests will be two-sided using an alpha level of 0.05.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date November 2014
Est. primary completion date September 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age eighteen and over

- Able to consent

Study Design

Observational Model: Case-Crossover, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Canada North Toronto Primary Care Research Network Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
North Toronto Primary Care Research Network

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary mean value of the last five systolic blood pressures for each location within the offices comparison between the mean systolic values of the automated blood pressure measurements using a BpTRU device in private (quiet, no interactions with health care personnel) and non private areas of the offices. 1 hour No
Secondary comparison of first and second sets of blood pressure readings Determination of rank effect on automated blood pressure measurements 1 hour No
Secondary comparisons of automated BP readings for patients with and without previously documented hypertension 1 hour No
Secondary effect of office decibel levels on automated office BP readings 1 hour No
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A